Therefore, this study took Chinese patients with DKD as the research objects and conducted a systematic review and meta-analysis of the results of published case-control studies, aiming to explore the relationship between serum osteocalcin levels and DKD progression and provide new ideas and evidence-based medical evidence for the clinical prevention and treatment of bone metabolism abnormalities in patients with DKD. This evidence concerns the gene BGLAP and diabetic kidney disease.